Skip to main navigation Skip to search Skip to main content

Persistent polyclonal B lymphocytosis with Epstein-Barr virus antibodies and subsequent malignant pulmonary blastoma

  • FRANK SULLIVAN

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

32 Citations (Scopus)

Abstract

Persistent polyclonal B lymphocytosis (PPBL), a rare benign lymphoproliferative disorder, occurred in a 25 year old woman. The lymphocytes showed the phenotype cIgM+, FMC7+, CD19+, CD20+, which was similar to that seen in Waldenstrom's macroglobinaemia, but the proliferation was repeatedly shown to be polyclonal both immunologically and by immunoglobulin gene rearrangement studies. Eleven years after presentation the patient developed a malignant pulmonary blastoma, a rare pulmonary tumour of combined epithelial and mesenchymal origin. The failure to develop a lymphoid malignancy over 11 years together with immunological and genetic evidence of polyclonality confirms that PPBL is a benign lymphoproliferative disorder. The subsequent occurrence of a non-haemopoietic malignancy suggests that benign lymphoid proliferations, like their malignant counterparts, may predispose to the development of neoplasia. A role for Epstein-Barr virus in the pathogenesis of one or both of these rare conditions is suggested by the finding of raised Epstein-Barr viral capsid antigen titres.

Original languageEnglish (Ireland)
Pages (from-to)341-342
Number of pages2
JournalJournal Of Clinical Pathology
Volume44
Issue number4
Publication statusPublished - 1 Apr 1991

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Authors (Note for portal: view the doc link for the full list of authors)

  • Authors
  • Lawlor E, Murray M, OBriain DS, Blaney C, Faroni L, Sarsfield P, Condell D, Sullivan F, McCann SR

Fingerprint

Dive into the research topics of 'Persistent polyclonal B lymphocytosis with Epstein-Barr virus antibodies and subsequent malignant pulmonary blastoma'. Together they form a unique fingerprint.

Cite this